Bright Rock Capital Management’s Gilead Sciences GILD Stock Holding History

Bright Rock Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-115,000	Closed	-$7.81M	–	89
2017 Q1	$7.81M	Buy	115,000 +9,000	+8%	+$633K	2.33%	6
2016 Q4	$7.59M	Buy	106,000 +8,000	+8%	+$595K	2.35%	6
2016 Q3	$7.75M	Buy	98,000 +9,775	+11%	+$794K	2.46%	6
2016 Q2	$7.36M	Buy	88,225 +13,000	+17%	+$1.15M	2.38%	5
2016 Q1	$6.91M	Buy	75,225 +11,225	+18%	+$1.01M	2.36%	5
2015 Q4	$6.48M	Buy	64,000 +7,000	+12%	+$728K	2.4%	5
2015 Q3	$5.6M	Hold	57,000	–	–	2.24%	9
2015 Q2	$6.67M	Sell	57,000 -6,000	-10%	-$656K	2.48%	2
2015 Q1	$6.18M	Buy	63,000 +1,000	+2%	+$102K	2.31%	5
2014 Q4	$5.84M	Buy	62,000 +3,000	+5%	+$310K	2.28%	6
2014 Q3	$6.28M	Sell	59,000 -16,000	-21%	-$1.57M	2.68%	4
2014 Q2	$6.22M	Sell	75,000 -1,000	-1%	-$77.8K	2.92%	6
2014 Q1	$5.38M	Buy	76,000 +21,000	+38%	+$1.65M	2.74%	7
2013 Q4	$4.13M	Sell	55,000 -4,000	-7%	-$279K	2.17%	18
2013 Q3	$3.71M	Buy	+59,000	New	+$3.53M	2.08%	20

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bright Rock Capital Management's GILD Position: Q2 2017 in Review

Bright Rock Capital Management sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 115,000 shares — an estimated $7.81M sold.

Bright Rock Capital Management first reported a position in GILD in Q3 2013 and held it in 15 quarters. The position peaked at $7.81M in Q1 2017. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Bright Rock Capital Management reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
Bright Rock Capital Management sold 115,000 Gilead Sciences shares in Q2 2017, an estimated $7.81M.
Bright Rock Capital Management first reported a position in Gilead Sciences in Q3 2013 and held it in 15 quarters.
Bright Rock Capital Management's Gilead Sciences position peaked at $7.81M in Q1 2017.
1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Bright Rock Capital Management's 13F filing for Q2 2017, filed 1 Aug 2017.